New vaccines and technologies
Introduction
WHO
|
The six traditional vaccines against tuberculosis (BCG), diphtheria, tetanus, pertussis, polio (OPV) and measles for their regular infant immunization schedule have contributed to the prevention of millions of unnecessary deaths. Many vaccines, however, exist and are now increasingly offered to all infants in many countries allowing for additional prevention of untimely deaths and disabilities. Those include vaccines against yellow fever, rubella, hepatitis B, invasive haemophilus influenzae type b (Hib) disease and Japanese encephalitis. In order to achieve the Millenium Development Goal of reducing child mortality, the expanded use of those new vaccines will be necessary.
Other promising vaccines against numerous important public health problems are currently under development or being improved. In addition, several technological improvements are being developed to simplify the transport, storage and administration of vaccines. The availability of additional new vaccines and supportive technologies by 2015 will contribute to reduce further the burden of infectious diseases, in particular for the countries that are the most affected by those problems.
More information
Implementation of new and under-utilized vaccines
More
Vaccine product selection menu
More
New vaccines projects
More
New technologies
More
::
The evolving vaccine pipeline 2007 [pdf 320kb]
|
